8 Results

People

  1. Zelenetz
    Zelenetz
  2. Horwitz
    Horwitz
  3. Hamlin
    Hamlin
  4. Kumar
    Kumar
  5. Matasar
    Matasar
  6. Moskowitz
    Moskowitz
  7. Noy
    Noy
  8. Younes
    Younes
  9. Moskowitz
    Moskowitz
  10. Palomba
    Palomba

Groups

  1. Center for Hematologic Malignancies (8)
  2. Department of Medicine (8)
  3. Hematologic Malignancies, Division of (8)
  4. Lymphoma (8)
  5. Population Sciences Research Program (8)
  6. Survivorship Research (7)
  7. Executive Committee, Center for Hematologic Malignancies (6)
  8. Biostatistics Service (5)
  9. Epidemiology and Biostatistics (5)
  10. Molecular Imaging and Therapy Service (5)
  1. "female"
  2. "Population Sciences Research Program"
  3. "Andrew Zelenetz"
Formats
  1. Journal Article (8)
Groups
  1. Center for Hematologic Malignancies (8)
  2. Department of Medicine (8)
  3. Hematologic Malignancies, Division of (8)
  4. Lymphoma (8)
  5. Population Sciences Research Program (8)
  6. Survivorship Research (7)

More Groups

People
  1. Andrew Zelenetz (8)
  2. David Straus (7)
  3. Steven Horwitz (7)
  4. Alison Moskowitz (6)
  5. Anas Younes (6)
  6. Anita Kumar (6)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2020 (2)
  4. 2017 (1)
  5. 2015 (1)
  6. 2004 (1)

More Years

Publications
  1. Blood (1)
  2. Blood Advances (1)
  3. Blood Cancer Journal (1)
  4. British Journal of Haematology (1)
  5. Clinical Cancer Research (1)
  6. Haematologica (1)

More Publications

Publishers
  1. American Society of Hematology (2)
  2. American Association for Cancer Research (1)
  3. Elsevier Science, Inc. (1)
  4. Ferrata Storti Foundation (1)
  5. John Wiley & Sons (1)
  6. Nature Publishing Group (1)

More Publishers

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Diffuse large B-cell lymphoma involving osseous sites: Utility of response assessment by PET/CT and good long-term outcomes
    Journal Article

    Ghione, P.; Ahsanuddin, S.; Luttwak, E.; Varela, S. B.; Nakajima, R.; Michaud, L.; Gupta, K.; Navitski, A.; Straus, D.; Palomba, M. L.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Phase I/Ib study of the efficacy and safety of buparlisib and ibrutinib therapy in MCL, FL, and DLBCL with serial cell-free DNA monitoring
    Journal Article

    Stewart, C. M.; Michaud, L.; Whiting, K.; Nakajima, R.; Nichols, C.; De Frank, S.; Hamlin, P. A. Jr; Matasar, M. J.; Gerecitano, J. F.; Drullinsky, P.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
    Journal Article

    Sermer, D.; Batlevi, C.; Lia Palomba, M.; Shah, G.; Lin, R. J.; Perales, M. A.; Scordo, M.; Dahi, P.; Pennisi, M.; Afuye, A.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Follicular lymphoma in the modern era: Survival, treatment outcomes, and identification of high-risk subgroups
    Journal Article

    Batlevi, C. L.; Sha, F.; Alperovich, A.; Ni, A.; Smith, K.; Ying, Z.; Soumerai, J. D.; Caron, P. C.; Falchi, L.; Hamilton, A.; more...
    Blood Cancer Journal (2020)

    Fulltext@MSK | Save
  • Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Schòˆder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Cadzin, B. R.; Fox, S. Y.; Gerecitano, J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: A non-randomised, open-label, single-centre, phase 2 study
    Journal Article

    Moskowitz, A. J.; Schòˆder, H.; Yahalom, J.; Mccall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin's disease
    Journal Article

    Portlock, C. S.; Donnelly, G. B.; Qin, J.; Straus, D.; Yahalom, J.; Zelenetz, A.; Noy, A.; O'connor, O.; Horwitz, S.; Moskowitz, C.; more...
    British Journal of Haematology (2004)

    Fulltext@MSK | Save
  • Patient-specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with 131I-anti-B1 antibody: Assessment of tumor dose-response
    Journal Article

    Sgouros, G.; Squeri, S.; Ballangrud, A. M.; Kolbert, K. S.; Teitcher, J. B.; Panageas, K. S.; Finn, R. D.; Divgi, C. R.; Larson, S. M.; Zelenetz, A. D.
    Journal of Nuclear Medicine (2003)

    Fulltext@MSK | Save